AJP - Heart and Circulatory Physiology, Vol 270, Issue 4 1264-H1271, Copyright © 1996 by American Physiological Society

ARTICLES

Functional antagonism between cAMP and cGMP on permeability of coronary endothelial monolayers

A. Hempel, T. Noll, A. Muhs and H. M. Piper
Physiologisches Institut, Justus-Liebig-Universitat, Giessen, Germany.

The role of the intracellular second messengers guanosine 3', 5'-cyclic monophosphate (cGMP) and adenosine 3', 5'-cyclic monophosphate (cAMP) in the control of macromolecule permeability was studied in cultured monolayers of microvascular coronary endothelial cells from rat. Macromolecule permeability was determined as passage of fluorescein isothiocyanate (FITC)-labeled albumin across the monolayers. Activation of adenylyl cyclase by the beta-adrenoceptor agonist isoproterenol (Iso; 10(-5) M) and the A2-adenosine receptor agonist 5'-(N-ethylcarboxamido)-adenosine (NECA; 10(-7) M) induced an increase in cellular cAMP contents that was accompanied by an increase in albumin flux. Effects of Iso and NECA on cellular cAMP level and albumin flux could be antagonized by a stimulator of the particular guanylyl cyclase, atrial natriuretic peptide (ANP; 10(-7) M), and stimulators of the soluble guanylyl cyclase, 3-morpholinosydnonimine (SIN-1; 10(-7) M) and sodium nitroprusside (SNP; 10(-6) M). ANP, SIN-1, and SNP also reduced cAMP content and basal macromolecule flux in unstimulated monolayers. 8-Bromoguanosine 3', 5'-cyclic monophosphate (8-BrcGMP; 5 x 10(-6) M), a stimulator of protein kinase G, reduced the increase in albumin flux under Iso (10(-5) M), NECA (10(-7) M), or 8-bromoadenosine 3', 5'-cyclic monophosphate (8-BrcAMP; 5 x 10(-6) M). The present study shows that cGMP and cAMP are functional antagonists in the control of macro molecule permeability.

This article has been cited by other articles:

				V. H. Huxley, J. J. Wang, and I. H. Sarelius Adaptation of coronary microvascular exchange in arterioles and venules to exercise training and a role for sex in determining permeability responses Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1196 - H1205. [Abstract] [Full Text] [PDF]

				V. H. Huxley, J. Wang, and S. P. Whitt Sexual dimorphism in the permeability response of coronary microvessels to adenosine Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H2006 - H2013. [Abstract] [Full Text] [PDF]

				K. Bindewald, D. Gunduz, F. Hartel, S. C. Peters, C. Rodewald, S. Nau, M. Schafer, J. Neumann, H. M. Piper, and T. Noll Opposite effect of cAMP signaling in endothelial barriers of different origin Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1246 - C1255. [Abstract] [Full Text] [PDF]

				L. Agullo, D. Garcia-Dorado, N. Escalona, M. Ruiz-Meana, J. Inserte, and J. Soler-Soler Effect of ischemia on soluble and particulate guanylyl cyclase-mediated cGMP synthesis in cardiomyocytes Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2170 - H2176. [Abstract] [Full Text] [PDF]

				L. Agullo, D. Garcia-Dorado, N. Escalona, J. Inserte, M. Ruiz-Meana, J. A. Barrabes, M. Mirabet, P. Pina, and J. Soler-Soler Hypoxia and acidosis impair cGMP synthesis in microvascular coronary endothelial cells Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H917 - H925. [Abstract] [Full Text] [PDF]

				P. He, M. Zeng, and F. E. Curry Dominant role of cAMP in regulation of microvessel permeability Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1124 - H1133. [Abstract] [Full Text] [PDF]

				C. C. Michel and F. E. Curry Microvascular Permeability Physiol Rev, July 1, 1999; 79(3): 703 - 761. [Abstract] [Full Text] [PDF]

				J. Knapp, P. Bokník, I. Lüss, S. Huke, B. Linck, H. Lüss, F. U. Müller, T. Müller, P. Nacke, T. Noll, et al. The Protein Phosphatase Inhibitor Cantharidin Alters Vascular Endothelial Cell Permeability J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1480 - 1486. [Abstract] [Full Text]

				T. Noll, H. Holschermann, K. Koprek, D. Gunduz, W. Haberbosch, H. Tillmanns, and H. M. Piper ATP reduces macromolecule permeability of endothelial monolayers despite increasing [Ca2+]i Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1892 - H1901. [Abstract] [Full Text] [PDF]

				T. Noll, G. Wozniak, K. McCarson, A. Hajimohammad, H. J. Metzner, J. Inserte, W. Kummer, F. W. Hehrlein, and H. M. Piper Effect of Factor XIII on Endothelial Barrier Function J. Exp. Med., May 3, 1999; 189(9): 1373 - 1382. [Abstract] [Full Text] [PDF]

				L. F. Richard, T. E. Dahms, and R. O. Webster Adenosine prevents permeability increase in oxidant-injured endothelial monolayers Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H35 - H42. [Abstract] [Full Text] [PDF]